Liver health key to drug dosing: new study tests LY3502970
NCT ID NCT05882032
First seen Jun 02, 2026 · Last updated Jun 13, 2026 · Updated 4 times
Summary
This study looked at how the drug LY3502970 moves through the body in people with different levels of liver function. 29 adults with healthy livers or mild, moderate, or severe liver impairment received a single dose. Researchers measured drug levels in the blood to understand how liver problems change drug clearance, helping guide future safe dosing.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Clinical Pharmacology of Miami
Miami, Florida, 33014, United States
-
Orlando Clinical Research Center
Orlando, Florida, 32809, United States
-
Pinnacle Clinical Research
San Antonio, Texas, 78229, United States
-
Texas Liver Institute
San Antonio, Texas, 78215, United States
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.